AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Relay Therapeutics to Present at Cowen 39th Annual Health Care Conference

March 5, 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 5, 2019--Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced that Sanjiv K. Patel, M.A., M.D., MBA, president and chief executive officer, will present a company overview at the Cowen 39 th Annual Health Care Conference on Monday, March 11, 2019 at 11:30 a.m. ET. The conference is being held March 11-13, 2019 in Boston.

About Relay Therapeutics
Relay Therapeutics is committed to creating medicines that will have a transformative impact on patients by building a unique discovery platform centered on understanding how the conformation of proteins relate to function. Whereas prior approaches to imaging proteins have been limited to static pictures, Relay Therapeutics’ approach overcomes this challenge by combining unprecedented computational power with leading edge experimental techniques in structural biology, biophysics, chemistry and biology. This integration illuminates – for the first time – the full mobility of a protein and provides key insights into how the dynamic nature of a protein’s conformation regulates function. By applying these insights, Relay Therapeutics aims to modulate protein conformation to develop novel therapies for patients. The company’s initial programs are focused on developing therapeutics in oncology. Headquartered in Cambridge, Massachusetts, Relay Therapeutics is a private company launched in 2016. To date the company has raised $520M from investors including Third Rock Ventures, SoftBank Vision Fund, GV, Casdin Capital, BVF Partners, EcoR1 Capital, Foresite Capital, Perceptive Advisors, Tavistock Group and an affiliate of D.E. Shaw Research.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190305005709/en/

CONTACT: Dan Budwick, 1AB

(973) 271-6085

dan@1abmedia.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Relay Therapeutics

Copyright Business Wire 2019.

PUB: 03/05/2019 11:02 AM/DISC: 03/05/2019 11:01 AM

http://www.businesswire.com/news/home/20190305005709/en